FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland January 30, 2020. REUTERS/Arnd Wiegmann/File Photo ZURICH (Reuters) – Roche said a new port delivery system (PDS) for its eye drug Lucentis was as good as monthly injections in blindness-causing macular degeneration, as the Swiss drugmaker aims to refresh…

Leave a Reply

Your email address will not be published. Required fields are marked *